A Phase 1/2 Study of an Investigational Drug, ALN-CC5, in Healthy Adult Volunteers and Patients With PNH

Clinical trial NCT02352493 · COMPLETED

Trial details

NCT number: NCT02352493
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start date: 2015-01-01
Primary completion: 2016-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.